|

IM-1021 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Immunome, Inc.1

Indications

  • Solid Malignancies1
  • Hematologic Malignancies1
  • Cancer1

Duarte, California1 trial

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

City Of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.